Current management of parainfluenza pneumonitis in immunocompromised patients: a review

Ann R FalseyUniversity of Rochester, Rochester General Hospital, Rochester, NY, USAAbstract: Parainfluenza viruses (PIV) are common respiratory viruses that belong to the Paramyxoviridae family. PIV infection can lead to a wide variety of clinical syndromes ranging from mild upper respiratory illnes...

Full description

Bibliographic Details
Main Author: Falsey AR
Format: Article
Language:English
Published: Dove Medical Press 2012-08-01
Series:Infection and Drug Resistance
Online Access:http://www.dovepress.com/current-management-of-parainfluenza-pneumonitis-in-immunocompromised-p-a10645
_version_ 1818265387843715072
author Falsey AR
author_facet Falsey AR
author_sort Falsey AR
collection DOAJ
description Ann R FalseyUniversity of Rochester, Rochester General Hospital, Rochester, NY, USAAbstract: Parainfluenza viruses (PIV) are common respiratory viruses that belong to the Paramyxoviridae family. PIV infection can lead to a wide variety of clinical syndromes ranging from mild upper respiratory illness to severe pneumonia. Severe disease can be seen in elderly or chronically ill persons and may be fatal in persons with compromised immune systems, particularly children with severe combined immunodeficiency disease syndrome and hematopathic stem cell transplant recipients. At present, there are no licensed antiviral agents for the treatment of PIV infection. Aerosolized or systemic ribavirin in combination with intravenous gamma globulin has been reported in small, uncontrolled series and case reports of immunocompromised patients. A number of agents show antiviral activity in vitro and in animals, but none are currently approved for human use.Keywords: parainfluenza virus, antiviral agents, immunocompromised host
first_indexed 2024-12-12T19:50:00Z
format Article
id doaj.art-f10393acb7ed4278aee080a4d1c20dde
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-12T19:50:00Z
publishDate 2012-08-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-f10393acb7ed4278aee080a4d1c20dde2022-12-22T00:13:59ZengDove Medical PressInfection and Drug Resistance1178-69732012-08-012012default121127Current management of parainfluenza pneumonitis in immunocompromised patients: a reviewFalsey ARAnn R FalseyUniversity of Rochester, Rochester General Hospital, Rochester, NY, USAAbstract: Parainfluenza viruses (PIV) are common respiratory viruses that belong to the Paramyxoviridae family. PIV infection can lead to a wide variety of clinical syndromes ranging from mild upper respiratory illness to severe pneumonia. Severe disease can be seen in elderly or chronically ill persons and may be fatal in persons with compromised immune systems, particularly children with severe combined immunodeficiency disease syndrome and hematopathic stem cell transplant recipients. At present, there are no licensed antiviral agents for the treatment of PIV infection. Aerosolized or systemic ribavirin in combination with intravenous gamma globulin has been reported in small, uncontrolled series and case reports of immunocompromised patients. A number of agents show antiviral activity in vitro and in animals, but none are currently approved for human use.Keywords: parainfluenza virus, antiviral agents, immunocompromised hosthttp://www.dovepress.com/current-management-of-parainfluenza-pneumonitis-in-immunocompromised-p-a10645
spellingShingle Falsey AR
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Infection and Drug Resistance
title Current management of parainfluenza pneumonitis in immunocompromised patients: a review
title_full Current management of parainfluenza pneumonitis in immunocompromised patients: a review
title_fullStr Current management of parainfluenza pneumonitis in immunocompromised patients: a review
title_full_unstemmed Current management of parainfluenza pneumonitis in immunocompromised patients: a review
title_short Current management of parainfluenza pneumonitis in immunocompromised patients: a review
title_sort current management of parainfluenza pneumonitis in immunocompromised patients a review
url http://www.dovepress.com/current-management-of-parainfluenza-pneumonitis-in-immunocompromised-p-a10645
work_keys_str_mv AT falseyar currentmanagementofparainfluenzapneumonitisinimmunocompromisedpatientsareview